Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state

Biochemistry
M RamachandraI Pastan

Abstract

Human P-glycoprotein (Pgp), a plasma membrane protein that confers multidrug resistance, functions as an ATP-dependent drug efflux pump. Pgp contains two ATP binding/utilization sites and exhibits ATPase activity that is stimulated in the presence of substrates and modulating agents. The mechanism of coupling of ATP hydrolysis to drug transport is not known. To understand the role of ATP hydrolysis in drug binding, it is necessary to develop methods for purifying and reconstituting Pgp that retains properties including stimulation of ATPase activity by known substrates to an extent similar to that in the native membrane. In this study, (His)6-tagged Pgp was expressed in Trichoplusia ni (High Five) cells using the recombinant baculovirus system and purified by metal affinity chromatography. Upon reconstitution into phospholipid vesicles, purified Pgp exhibited specific binding to analogues of substrates and ATP in affinity labeling experiments and displayed a high level of drug-stimulated ATPase activity (specific activity ranging from 4.5 to 6.5 micromol min-1 mg-1). The ATPase activity was inhibited by ADP in a competitive manner, and by vanadate and N-ethylmaleimide at low concentrations. Vanadate which is known to inhibit AT...Continue Reading

References

Jul 1, 1987·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·M M CornwellI Pastan
Jan 1, 1983·Annual Review of Biochemistry·C Tanford
Jan 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·C C Goodno, E W Taylor
Feb 1, 1995·Journal of Bioenergetics and Biomembranes·S V Ambudkar
Feb 1, 1995·Journal of Bioenergetics and Biomembranes·A E SeniorI L Urbatsch
Jan 1, 1993·Annual Review of Biochemistry·M M Gottesman, I Pastan
Jan 19, 1996·The Journal of Biological Chemistry·U A GermannM M Gottesman
Jul 5, 1996·The Journal of Biological Chemistry·I Rayment
Jan 1, 1995·Annual Review of Genetics·M M GottesmanI Pastan

❮ Previous
Next ❯

Citations

Feb 4, 2006·The Journal of Membrane Biology·T W Loo, D M Clarke
May 13, 2006·Journal of Bioenergetics and Biomembranes·Frances J SharomPaul D W Eckford
May 15, 2007·Pharmaceutical Research·Karsten BucherStefanie D Krämer
Aug 9, 2002·Biochemical Pharmacology·Songyot AnuchapreedaPorn-ngarm Limtrakul
Jun 13, 2002·Il Farmaco·E TeodoriF Gualtieri
Aug 15, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alexander V KabanovValery Yu Alakhov
Sep 3, 2002·Advanced Drug Delivery Reviews·Alexander V KabanovValery Yu Alakhov
Jan 22, 2003·Advanced Drug Delivery Reviews·Jiunn H Lin
Sep 29, 2004·Nature Structural & Molecular Biology·Christopher F Higgins, Kenneth J Linton
Mar 27, 2002·The Pharmacogenomics Journal·U Brinkmann, M Eichelbaum
Jun 6, 2002·European Journal of Biochemistry·Katalin GodaGábor Szabó
Jul 26, 2011·Planta medica·Wisinee ChanmahasathienPornngarm Limtrakul
Jan 12, 2010·The Journal of Biological Chemistry·Alena SiarheyevaFrances J Sharom
Oct 21, 2010·The Journal of Biological Chemistry·Jinming CuiAmy L Davidson
Oct 30, 2008·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Kaspar P Locher
Mar 30, 2004·Antimicrobial Agents and Chemotherapy·Sanjay U C SankatsingJan M Prins
Apr 16, 2009·Clinical Microbiology Reviews·Richard D CannonBrian C Monk
Jan 12, 2007·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Ravindra AuradeKuruba Sreeramulu
Jun 11, 2004·Annual Review of Biochemistry·Amy L Davidson, Jue Chen
May 20, 1999·Annual Review of Pharmacology and Toxicology·S V AmbudkarM M Gottesman
Mar 2, 2006·Biological & Pharmaceutical Bulletin·Tamihide MatsunagaShigeru Ohmori
Dec 20, 2002·Clinical Pharmacokinetics·Jiunn H Lin, Masayo Yamazaki
Nov 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Andrew WardGeoffrey Chang
Mar 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·Z E Sauna, S V Ambudkar
Jun 26, 2014·Future Medicinal Chemistry·Nicholas R Natale, Scott A Steiger
Mar 6, 2004·Expert Review of Molecular Diagnostics·János KappelmayerZsuzsa Hevessy
Dec 29, 2005·FEBS Letters·Richard CallaghanIan D Kerr
Aug 23, 2006·Expert Opinion on Drug Metabolism & Toxicology·Nicole H P CnubbenPeter J van Bladeren
Nov 24, 2004·Drug Metabolism Reviews·Ulrich Hoffmann, Heyo K Kroemer
Aug 1, 2008·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S-F Zhou
Dec 3, 2014·Biochimica Et Biophysica Acta·Kim S HorgerMichael Mayer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.